We assessed total and cytoplasmic HSP110 expression in gastric cancer samples, but no significant prognostic differences were observed in the total and cytoplasmic HSP110 expression between the high and low groups (Supplementary Figures S1, S2). The gene discussed is HSPH1; the disease is gastric cancer.